BioMEMS / (Registro nro. 278696)
[ vista simple ]
000 -CABECERA | |
---|---|
campo de control de longitud fija | 08224nam a22003495i 4500 |
001 - NÚMERO DE CONTROL | |
campo de control | 278696 |
003 - IDENTIFICADOR DEL NÚMERO DE CONTROL | |
campo de control | MX-SnUAN |
005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN | |
campo de control | 20160429153914.0 |
007 - CAMPO FIJO DE DESCRIPCIÓN FÍSICA--INFORMACIÓN GENERAL | |
campo de control de longitud fija | cr nn 008mamaa |
008 - DATOS DE LONGITUD FIJA--INFORMACIÓN GENERAL | |
campo de control de longitud fija | 150903s2006 xxu| o |||| 0|eng d |
020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO | |
Número Internacional Estándar del Libro | 9780387287324 |
-- | 978-0-387-28732-4 |
024 7# - IDENTIFICADOR DE OTROS ESTÁNDARES | |
Número estándar o código | 10.1007/9780387287324 |
Fuente del número o código | doi |
035 ## - NÚMERO DE CONTROL DEL SISTEMA | |
Número de control de sistema | vtls000330579 |
039 #9 - NIVEL DE CONTROL BIBLIOGRÁFICO Y DETALLES DE CODIFICACIÓN [OBSOLETO] | |
Nivel de reglas en descripción bibliográfica | 201509030438 |
Nivel de esfuerzo utilizado para asignar no-encabezamientos de materia en puntos de acceso | VLOAD |
Nivel de esfuerzo utilizado en la asignación de encabezamientos de materia | 201404121716 |
Nivel de esfuerzo utilizado para asignar clasificación | VLOAD |
Nivel de esfuerzo utilizado en la asignación de encabezamientos de materia | 201404091453 |
Nivel de esfuerzo utilizado para asignar clasificación | VLOAD |
Nivel de esfuerzo utilizado en la asignación de encabezamientos de materia | 201401311346 |
Nivel de esfuerzo utilizado para asignar clasificación | staff |
-- | 201401291458 |
-- | staff |
-- | msplit0.mrc |
-- | 999 |
050 #4 - CLASIFICACIÓN DE LA BIBLIOTECA DEL CONGRESO | |
Número de clasificación | TK7888.4 |
100 1# - ENTRADA PRINCIPAL--NOMBRE DE PERSONA | |
Nombre de persona | Urban, Gerald A. |
Término indicativo de función/relación | editor. |
9 (RLIN) | 302488 |
245 10 - MENCIÓN DE TÍTULO | |
Título | BioMEMS / |
Mención de responsabilidad, etc. | edited by Gerald A. Urban. |
264 #1 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT | |
Producción, publicación, distribución, fabricación y copyright | Boston, MA : |
Nombre del de productor, editor, distribuidor, fabricante | Springer US, |
Fecha de producción, publicación, distribución, fabricación o copyright | 2006. |
300 ## - DESCRIPCIÓN FÍSICA | |
Extensión | XIX, 373 p. |
Otras características físicas | recurso en línea. |
336 ## - TIPO DE CONTENIDO | |
Término de tipo de contenido | texto |
Código de tipo de contenido | txt |
Fuente | rdacontent |
337 ## - TIPO DE MEDIO | |
Nombre/término del tipo de medio | computadora |
Código del tipo de medio | c |
Fuente | rdamedia |
338 ## - TIPO DE SOPORTE | |
Nombre/término del tipo de soporte | recurso en línea |
Código del tipo de soporte | cr |
Fuente | rdacarrier |
347 ## - CARACTERÍSTICAS DEL ARCHIVO DIGITAL | |
Tipo de archivo | archivo de texto |
Formato de codificación | |
Fuente | rda |
490 0# - MENCIÓN DE SERIE | |
Mención de serie | Microsystems, |
Número Internacional Normalizado para Publicaciones Seriadas | 1389-2134 ; |
Designación de volumen o secuencia | 16 |
500 ## - NOTA GENERAL | |
Nota general | Springer eBooks |
505 0# - NOTA DE CONTENIDO CON FORMATO | |
Nota de contenido con formato | - EARLY BIOMEMS, MULTI-SENSOR NEUROPROBES. 1. INTRODUCTION . 2. EVOLUTION OF MICRO-SENSOR ARRAY DESIGNS FOR MEDICAL RESEARCH. 2.1.Electrical signal monitoring. 2.2.Sensor Design Evolution: from 2D to 3D. 2.3.Chamber-Type Electrochemical Oxygen Sensors. 3. OTHER APPLICATIONS – THE FIRST MICRO-FLUIDIC DEVICE. 4. CONCLUSION. 5. REFERENCES -- MULTI-PARAMETER BIOMEMS FOR CLINICAL MONITORING. 1. INTRODUCTION. 2. BIOSENSORS. 2.1.Principle of Biosensors. 2.2.Amperometric Biosensors. 2.3.Aspects of miniaturization and integration. 3. CLINICAL MONITORING. 3.1.Multi-analyte measurement. 3.2.Microdialysis. 3.3.BioMEMS for clinical monotoring. 3.4.Multiparameter monitoring. 3.5.Applications.. 4. CONCLUSIONS AND OUTLOOK. 5. REFERENCES -- BIOMEDICAL MICRODEVICES FOR NEURAL IMPLANTS. 1. INTRODUCTION TO NEURAL IMPLANTS. 2. ANATOMICAL AND BIOPHYSICAL FUNDAMENTALS. 2.1.Peripheral Nerve Anatomy. 2.2.Mechanisms of Peripheral Nerve Damage. 2.3.Excitability of Nerves. 2.4.Electrical Modeling of the Nerve Membrane. 2.5.Propagation of Action Potentials. 2.6.Extracellular Stimulation of Nerve Fibres. 2.7.Selective Activation of Nerve Fibres. 3. CLINICAL IMPLANTS. 3.1.Electrodes – The Key Component in Neural Prostheses. 3.2.Cardiac Pacemakers. 3.3.Implantable Defibrillators. 3.4.Cochlea Implants. 3.5.Phrenic Pacemakers. 3.6.Grasp Neuroprostheses . 3.7.Neuroprostheses for gait and posture. 3.8.Spinal Root Stimulator. 3.9.Drop Foot Stimulator. 3.10.Neuromodulation. 3.11.Deep Brain Stimulation. 3.12.Vagal Nerve Stimulation. 4. THE CHALLENGE OF MICROIMPLANTS. 5. VISION PROSTHESES. 5.1.Cortical Vision Prostheses. 5.2.Optic Nerve Vision Prosthesis . 5.3.Retinal Implants. 5.4.Conclusions on Vision Prostheses. 6. PERIPHERERAL NERVE INTERFACES. 6.1.Non-Invasive Nerve Interfaces. 6.2."Semi"-Invasive Interfaces. 6.3.Invasive Interfaces. 6.4.Biohybrid Approaches. 7.FUTURE APPLICATIONS. 7.1.Interfacing the Brain. 7.2.Spinal Cord Implants. 7.3.Multimodal Neural Implants. 8.CONCLUDING REMARKS. 9. NEURAL IMPLANTS: BOON OR BANE? 10. REFERENCES -- MICROFLUIDIC PLATFORMS . 1.INTRODUCTION. 2. WHAT IS A MICROFLUIDIC PLATFORM. 3. EXAMPLES OF MICROFLUIDIC PLATFORMS. 3.1.PDMS based Microfluidics for Large Scale Integration ("Fluidigm platform"). 3.2.Microfluidics on a Rotating Disk ("Lab-on-a-Disk"). 3.3.Droplet based microfluidics (DBM). 3.4.Non-contact liquid Dispensing. 4.CONCLUSION. REFERENCES -- DNA BASED BIO-MICRO-ELECTRONIC-MECHANICAL-SYSTEMS. 1.INTRODUCTION. 1.1.The unique features of nucleic acids. 1.2.Lab-on-the-Chip. 1.3.Biochemical reaction chains for integration: biosensors and the "lab-biochip". 2.MICROARRAYS AND BIOCHIPS BASED ON DNA. 2.1.The typical microarray experiment. 2.2.Manufacturing of Microarrays. 2.3Transcription Analysis. 2.4.Oligonucleotide Arrays for sequencing. 2.5.Active arrays. 2.6.Integrated PCR. 3. NANOBIOTECHNOLOGY: DNA AS MATERIAL. 3.1.DNA directed immobilisation and nucleic acid tags. 3.2.DNA for regular structures. 3.3.DNA to structure surfaces. 3.4.Metallisation of DNA for electronic circuits. 4.REFERENCES SEPARATION AND DETECTION ON A CHIP. 1.INTRODUCTION. 2.THEORY OF CAPILLARY ELECTROPHORESIS ON A CE-CHIP. 2.1.Mobility of ions. 2.2.Electroosmotic flow. 3.JOULE HEATING IN MICROFABRICATED DEVICES. 3.1.Separation efficiency of a CE-chip. 3.2.Separation of biomacromolecules and particles. 4.BUILDING BLOCKS OF CE-CHIP DEVICES. 4.1.Wafer materials, micromachining and wafer bonding. 4.2.Power supplies, pumping, injection and channel geometries. 4.3.Detection strategies. 5.SELECTED EXAMPLES FOR CE ON A CHIP. 6.DIELECTROPHORESIS. 7.OUTLOOK. 8.REFERENCES -- PROTEIN MICROARRAYS : APPLICATIONS AND FUTURE CHALLENGES. 1.INTRODUCTION. 2.FORWARD-PHASE PROTEIN MICROARRAYS. 2.1.Protein-Expression Analysis Using Protein Microarrays. 2.2.Protein Interaction Microarrays. 3.REVERSE MICROARRAYS. 4.OUTLOOK. 5.BIBLIOGRAPHY -- LAB-ON-A-CHIP SYSTEMS FOR CELLULAR ASSAYS . 1.INTRODUCTION . 2.DESIGN AND FABRICATION OF CHIPS FOR CELL BASED ASSAYS. 3.CELL CULTURE ON CHIPS AND MICROFLUIDIC SYSTEMS. 4.DETECTABLE CELLULAR OUTPUT SIGNALS. 4.1.Cell Metabolism. 4.2.Cell Morphology. 4.3.Electrical Patterns. 5.CELL MANIPULATION ON CHIPS. 6. CONCLUSIONS AND FUTURE PROSPECTS -- NETWORK ON CHIPS. 1.INTRODUCTION. 2.TECHNICAL ASPECTS AND UNDERLYING ASSUMPTIONS. 2.1.System requirements. 3.ORIGIN OF THE SIGNAL RECORDED. 4.SPATIAL RESOLUTION. 5.LFP AND PLASTICITY. 6.NETWORK DYNAMICS AND EPILEPTIFORM ACTIVITY. 7.DRUG TESTING WITH MEAS. 7.1.Using Network Properties as Endpoints in Drug Assays. 7.2.Assessing Distributions of Neuronal Responses to Dopamine. 7.3.Cardiopharmacology. 8.DATA ANALYSIS. 9.OUTLOOK -- BIONANOSYSTEMS. 1.INTRODUCTION. 2.BASIC CONCEPTS AND EXPERIMENTAL METHODS. 2.1.Self-assembly. 2.2.Optical properties of semiconducting nanocrystals. 2.3.Optical properties of metal nanocrystals. 2.4.Magnetic nanoparticles. 2.5.Conjugation of nanomaterials and biomolecules. 2.6.Bioanalysis with bionanosystems. 2.7.Imaging. 3.APPLICATIONS. 3.1.DNA detection. 3.2.Immunoassays. 3.3.Imaging. 4.CONCLUSION AND OUTLOOK. 5.ACKNOWLEDGEMENTS . 6.REFERENCES. |
520 ## - SUMARIO, ETC. | |
Sumario, etc. | Explosive growth in the field of microsystem technology (MST) has introduced a variety of promising products in major disciplines from microelectronics to life sciences. Especially the life sciences and health care business was, and is expected to be a major market for MST products. Undoubtedly the merging of biological sciences with micro- and nanoscience will create a scientific and technological revolution in future. Microminiaturization of devices, down to the nanoscale, approaching the size of biological structures, will be a prerequisite for the future success of life sciences. Bioanalytical and therapeutic micro- and nanosystems will be mandatory for system biologists in the long run, to obtain insight into morphology, the function and the interactive processes of the living system. With such a deeper understanding new and personalized drugs could be developed leading to a revolution in life sciences. Today, microanalytical devices are used in clinical analytics or molecular biology as gene chips. In parallel, standard microbiomedical products are employed in the intensive care and surgical theatre, mainly for monitoring and implantation purposes. The gap between these two different scientific fields will be closed, however, as soon as functional micro devices can be produced, allowing a deeper view into the function of cells and whole organisms. Here, a new discipline evolved which focuses on microsystems for living systems called "BIOMEMS". In this review at a glance the exciting field of bio-microsystems, from their beginnings to indicators of future successes are presented. It will also show that a broad penetration of micro and nano technologies into biology and medicine will be mandatory for future scientific and new product development progress in life science. |
710 2# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE ENTIDAD CORPORATIVA | |
Nombre de entidad corporativa o nombre de jurisdicción como elemento de entrada | SpringerLink (Servicio en línea) |
9 (RLIN) | 299170 |
776 08 - ENTRADA/ENLACE A UN FORMATO FÍSICO ADICIONAL | |
Información de relación/Frase instructiva de referencia | Edición impresa: |
Número Internacional Estándar del Libro | 9780387287317 |
856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS | |
Identificador Uniforme del Recurso | <a href="http://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-28732-4">http://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-28732-4</a> |
Nota pública | Conectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
942 ## - ELEMENTOS DE PUNTO DE ACCESO ADICIONAL (KOHA) | |
Tipo de ítem Koha | Recurso en línea |
No hay ítems disponibles.